RxDoctor Payments Data

Holly Wortley

Primary Care · Bountiful, UTNPI 1720732308

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 157 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 27 manufacturers reported payments, led by AbbVie at 25.7% of the total. 2025 is the largest year on record at $893, 3.1 times the $289 reported in 2022.

$2,763in general payments, 2019–2025

Across 157 payments — averaging $17.60 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$711
  • Indivior Inc.$505
  • Medtronic$298
  • AstraZeneca$253
  • Novo Nordisk$108
  • Lilly USA, LLC$102
  • plus $786 from 21 others

What the payments were for

  • Food & beverage$2,763100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,763 in reported general payments places this provider in the 80th percentile of 60 primary care providers in Utah.

See all primary care providers in Utah

Medicare billing

Part B allowed, 2024
$6,898
Medicare patients
31
Services billed
114

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl26$2,128
Np ThyroidThyroid,pork20$1,236
ProgesteroneProgesterone, Micronized38$802
Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine23$724
Bupropion Hcl SrBupropion Hcl15$662
Liothyronine Sodium35$651
Gabapentin34$642
Levothyroxine Sodium50$625
Propranolol Hcl18$393
Omeprazole20$386
Albuterol Sulfate HfaAlbuterol Sulfate15$336
Simvastatin20$325
Duloxetine Hcl11$281
Clonazepam19$278
Temazepam19$271

Paid to pharmacies, not to this prescriber.

Other primary care in Bountiful

See the full list for Utah

Where these figures come from

Is this you, or does something look wrong? →